カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のゴナドトロピン放出ホルモン拮抗薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Gonadotropin-releasing Hormone Antagonists Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19362）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19362
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のゴナドトロピン放出ホルモン拮抗薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ゴナドトロピン放出ホルモン拮抗薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のゴナドトロピン放出ホルモン拮抗薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ゴナドトロピン放出ホルモン拮抗薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ペプチド、低分子

用途別セグメントは次のように区分されます。
・前立腺がん、子宮内膜症、子宮筋腫、女性不妊症、その他

世界のゴナドトロピン放出ホルモン拮抗薬市場の主要な市場プレーヤーは以下のとおりです。
・AbbVie、Takeda、Astellas、Kissei、Veru Inc、Myovant Sciences、AstraZeneca、Ferring Pharmaceuticals、Jiangsu Hengrui Medicine Co

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ゴナドトロピン放出ホルモン拮抗薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なゴナドトロピン放出ホルモン拮抗薬メーカーの企業概要、2019年～2022年までのゴナドトロピン放出ホルモン拮抗薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なゴナドトロピン放出ホルモン拮抗薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ゴナドトロピン放出ホルモン拮抗薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのゴナドトロピン放出ホルモン拮抗薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのゴナドトロピン放出ホルモン拮抗薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびゴナドトロピン放出ホルモン拮抗薬の産業チェーンを掲載しています。
・第13、14、15章では、ゴナドトロピン放出ホルモン拮抗薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ゴナドトロピン放出ホルモン拮抗薬の概要
- 種類別分析（2017年vs2021年vs2028年）：ペプチド、低分子
- 用途別分析（2017年vs2021年vs2028年）：前立腺がん、子宮内膜症、子宮筋腫、女性不妊症、その他
- 世界のゴナドトロピン放出ホルモン拮抗薬市場規模・予測
- 世界のゴナドトロピン放出ホルモン拮抗薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AbbVie、Takeda、Astellas、Kissei、Veru Inc、Myovant Sciences、AstraZeneca、Ferring Pharmaceuticals、Jiangsu Hengrui Medicine Co
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ペプチド、低分子
・用途別分析2017年-2028年：前立腺がん、子宮内膜症、子宮筋腫、女性不妊症、その他
・ゴナドトロピン放出ホルモン拮抗薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ゴナドトロピン放出ホルモン拮抗薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ゴナドトロピン放出ホルモン拮抗薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ゴナドトロピン放出ホルモン拮抗薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ゴナドトロピン放出ホルモン拮抗薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Gonadotropin-releasing Hormone Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gonadotropin-releasing Hormone Antagonists market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Prostate Cancer accounting for % of the Gonadotropin-releasing Hormone Antagonists global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Peptides segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gonadotropin-releasing Hormone Antagonists include AbbVie, Takeda, Astellas, Kissei, and Veru Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gonadotropin-releasing Hormone Antagonists market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Peptides
Small Molecules
Market segment by Application can be divided into
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others
The key market players for global Gonadotropin-releasing Hormone Antagonists market are listed below:
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gonadotropin-releasing Hormone Antagonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gonadotropin-releasing Hormone Antagonists, with price, sales, revenue and global market share of Gonadotropin-releasing Hormone Antagonists from 2019 to 2022.
Chapter 3, the Gonadotropin-releasing Hormone Antagonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gonadotropin-releasing Hormone Antagonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gonadotropin-releasing Hormone Antagonists market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gonadotropin-releasing Hormone Antagonists.
Chapter 13, 14, and 15, to describe Gonadotropin-releasing Hormone Antagonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Gonadotropin-releasing Hormone Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gonadotropin-releasing Hormone Antagonists Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Peptides
1.2.3 Small Molecules
1.3 Market Analysis by Application
1.3.1 Overview: Global Gonadotropin-releasing Hormone Antagonists Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Prostate Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibroids
1.3.5 Female Infertility
1.3.6 Others
1.4 Global Gonadotropin-releasing Hormone Antagonists Market Size & Forecast
1.4.1 Global Gonadotropin-releasing Hormone Antagonists Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gonadotropin-releasing Hormone Antagonists Sales in Volume (2017-2028)
1.4.3 Global Gonadotropin-releasing Hormone Antagonists Price (2017-2028)
1.5 Global Gonadotropin-releasing Hormone Antagonists Production Capacity Analysis
1.5.1 Global Gonadotropin-releasing Hormone Antagonists Total Production Capacity (2017-2028)
1.5.2 Global Gonadotropin-releasing Hormone Antagonists Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gonadotropin-releasing Hormone Antagonists Market Drivers
1.6.2 Gonadotropin-releasing Hormone Antagonists Market Restraints
1.6.3 Gonadotropin-releasing Hormone Antagonists Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Gonadotropin-releasing Hormone Antagonists Product and Services
2.1.4 AbbVie Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Gonadotropin-releasing Hormone Antagonists Product and Services
2.2.4 Takeda Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Astellas
2.3.1 Astellas Details
2.3.2 Astellas Major Business
2.3.3 Astellas Gonadotropin-releasing Hormone Antagonists Product and Services
2.3.4 Astellas Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Kissei
2.4.1 Kissei Details
2.4.2 Kissei Major Business
2.4.3 Kissei Gonadotropin-releasing Hormone Antagonists Product and Services
2.4.4 Kissei Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Veru Inc
2.5.1 Veru Inc Details
2.5.2 Veru Inc Major Business
2.5.3 Veru Inc Gonadotropin-releasing Hormone Antagonists Product and Services
2.5.4 Veru Inc Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Myovant Sciences
2.6.1 Myovant Sciences Details
2.6.2 Myovant Sciences Major Business
2.6.3 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product and Services
2.6.4 Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Gonadotropin-releasing Hormone Antagonists Product and Services
2.7.4 AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ferring Pharmaceuticals
2.8.1 Ferring Pharmaceuticals Details
2.8.2 Ferring Pharmaceuticals Major Business
2.8.3 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product and Services
2.8.4 Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Jiangsu Hengrui Medicine Co
2.9.1 Jiangsu Hengrui Medicine Co Details
2.9.2 Jiangsu Hengrui Medicine Co Major Business
2.9.3 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product and Services
2.9.4 Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gonadotropin-releasing Hormone Antagonists Breakdown Data by Manufacturer
3.1 Global Gonadotropin-releasing Hormone Antagonists Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gonadotropin-releasing Hormone Antagonists
3.4 Market Concentration Rate
3.4.1 Top 3 Gonadotropin-releasing Hormone Antagonists Manufacturer Market Share in 2021
3.4.2 Top 6 Gonadotropin-releasing Hormone Antagonists Manufacturer Market Share in 2021
3.5 Global Gonadotropin-releasing Hormone Antagonists Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gonadotropin-releasing Hormone Antagonists Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gonadotropin-releasing Hormone Antagonists Market Size by Region
4.1.1 Global Gonadotropin-releasing Hormone Antagonists Sales in Volume by Region (2017-2028)
4.1.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2028)
4.2 North America Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028)
4.3 Europe Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028)
4.4 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028)
4.5 South America Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028)
4.6 Middle East and Africa Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gonadotropin-releasing Hormone Antagonists Sales in Volume by Type (2017-2028)
5.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2017-2028)
5.3 Global Gonadotropin-releasing Hormone Antagonists Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gonadotropin-releasing Hormone Antagonists Sales in Volume by Application (2017-2028)
6.2 Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2017-2028)
6.3 Global Gonadotropin-releasing Hormone Antagonists Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2028)
7.2 North America Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2028)
7.3 North America Gonadotropin-releasing Hormone Antagonists Market Size by Country
7.3.1 North America Gonadotropin-releasing Hormone Antagonists Sales in Volume by Country (2017-2028)
7.3.2 North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2028)
8.2 Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2028)
8.3 Europe Gonadotropin-releasing Hormone Antagonists Market Size by Country
8.3.1 Europe Gonadotropin-releasing Hormone Antagonists Sales in Volume by Country (2017-2028)
8.3.2 Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2028)
9.2 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2028)
9.3 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Market Size by Region
9.3.1 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2028)
10.2 South America Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2028)
10.3 South America Gonadotropin-releasing Hormone Antagonists Market Size by Country
10.3.1 South America Gonadotropin-releasing Hormone Antagonists Sales in Volume by Country (2017-2028)
10.3.2 South America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2028)
11.2 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2028)
11.3 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Market Size by Country
11.3.1 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gonadotropin-releasing Hormone Antagonists and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gonadotropin-releasing Hormone Antagonists
12.3 Gonadotropin-releasing Hormone Antagonists Production Process
12.4 Gonadotropin-releasing Hormone Antagonists Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gonadotropin-releasing Hormone Antagonists Typical Distributors
13.3 Gonadotropin-releasing Hormone Antagonists Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Gonadotropin-releasing Hormone Antagonists Product and Services
Table 6. AbbVie Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda Gonadotropin-releasing Hormone Antagonists Product and Services
Table 10. Takeda Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Astellas Basic Information, Manufacturing Base and Competitors
Table 12. Astellas Major Business
Table 13. Astellas Gonadotropin-releasing Hormone Antagonists Product and Services
Table 14. Astellas Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Kissei Basic Information, Manufacturing Base and Competitors
Table 16. Kissei Major Business
Table 17. Kissei Gonadotropin-releasing Hormone Antagonists Product and Services
Table 18. Kissei Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Veru Inc Basic Information, Manufacturing Base and Competitors
Table 20. Veru Inc Major Business
Table 21. Veru Inc Gonadotropin-releasing Hormone Antagonists Product and Services
Table 22. Veru Inc Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Myovant Sciences Basic Information, Manufacturing Base and Competitors
Table 24. Myovant Sciences Major Business
Table 25. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Product and Services
Table 26. Myovant Sciences Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Major Business
Table 29. AstraZeneca Gonadotropin-releasing Hormone Antagonists Product and Services
Table 30. AstraZeneca Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Ferring Pharmaceuticals Major Business
Table 33. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Product and Services
Table 34. Ferring Pharmaceuticals Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Jiangsu Hengrui Medicine Co Basic Information, Manufacturing Base and Competitors
Table 36. Jiangsu Hengrui Medicine Co Major Business
Table 37. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Product and Services
Table 38. Jiangsu Hengrui Medicine Co Gonadotropin-releasing Hormone Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Gonadotropin-releasing Hormone Antagonists Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Gonadotropin-releasing Hormone Antagonists Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Gonadotropin-releasing Hormone Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Gonadotropin-releasing Hormone Antagonists Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Gonadotropin-releasing Hormone Antagonists Production Site of Key Manufacturer
Table 44. Gonadotropin-releasing Hormone Antagonists New Entrant and Capacity Expansion Plans
Table 45. Gonadotropin-releasing Hormone Antagonists Mergers & Acquisitions in the Past Five Years
Table 46. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2017-2022) & (K Units)
Table 47. Global Gonadotropin-releasing Hormone Antagonists Sales by Region (2023-2028) & (K Units)
Table 48. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Gonadotropin-releasing Hormone Antagonists Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)
Table 51. Global Gonadotropin-releasing Hormone Antagonists Sales by Type (2023-2028) & (K Units)
Table 52. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Gonadotropin-releasing Hormone Antagonists Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Gonadotropin-releasing Hormone Antagonists Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Gonadotropin-releasing Hormone Antagonists Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)
Table 57. Global Gonadotropin-releasing Hormone Antagonists Sales by Application (2023-2028) & (K Units)
Table 58. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Gonadotropin-releasing Hormone Antagonists Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Gonadotropin-releasing Hormone Antagonists Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Gonadotropin-releasing Hormone Antagonists Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022) & (K Units)
Table 63. North America Gonadotropin-releasing Hormone Antagonists Sales by Country (2023-2028) & (K Units)
Table 64. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)
Table 67. North America Gonadotropin-releasing Hormone Antagonists Sales by Type (2023-2028) & (K Units)
Table 68. North America Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)
Table 69. North America Gonadotropin-releasing Hormone Antagonists Sales by Application (2023-2028) & (K Units)
Table 70. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022) & (K Units)
Table 71. Europe Gonadotropin-releasing Hormone Antagonists Sales by Country (2023-2028) & (K Units)
Table 72. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Gonadotropin-releasing Hormone Antagonists Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)
Table 75. Europe Gonadotropin-releasing Hormone Antagonists Sales by Type (2023-2028) & (K Units)
Table 76. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)
Table 77. Europe Gonadotropin-releasing Hormone Antagonists Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales by Application (2023-2028) & (K Units)
Table 86. South America Gonadotropin-releasing Hormone Antagonists Sales by Country (2017-2022) & (K Units)
Table 87. South America Gonadotropin-releasing Hormone Antagonists Sales by Country (2023-2028) & (K Units)
Table 88. South America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Gonadotropin-releasing Hormone Antagonists Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)
Table 91. South America Gonadotropin-releasing Hormone Antagonists Sales by Type (2023-2028) & (K Units)
Table 92. South America Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)
Table 93. South America Gonadotropin-releasing Hormone Antagonists Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales by Application (2023-2028) & (K Units)
Table 102. Gonadotropin-releasing Hormone Antagonists Raw Material
Table 103. Key Manufacturers of Gonadotropin-releasing Hormone Antagonists Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Gonadotropin-releasing Hormone Antagonists Typical Distributors
Table 107. Gonadotropin-releasing Hormone Antagonists Typical Customers
List of Figures
Figure 1. Gonadotropin-releasing Hormone Antagonists Picture
Figure 2. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type in 2021
Figure 3. Peptides
Figure 4. Small Molecules
Figure 5. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application in 2021
Figure 6. Prostate Cancer
Figure 7. Endometriosis
Figure 8. Uterine Fibroids
Figure 9. Female Infertility
Figure 10. Others
Figure 11. Global Gonadotropin-releasing Hormone Antagonists Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Gonadotropin-releasing Hormone Antagonists Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Gonadotropin-releasing Hormone Antagonists Sales (2017-2028) & (K Units)
Figure 14. Global Gonadotropin-releasing Hormone Antagonists Price (2017-2028) & (USD/Unit)
Figure 15. Global Gonadotropin-releasing Hormone Antagonists Production Capacity (2017-2028) & (K Units)
Figure 16. Global Gonadotropin-releasing Hormone Antagonists Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Gonadotropin-releasing Hormone Antagonists Market Drivers
Figure 18. Gonadotropin-releasing Hormone Antagonists Market Restraints
Figure 19. Gonadotropin-releasing Hormone Antagonists Market Trends
Figure 20. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Manufacturer in 2021
Figure 21. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Manufacturer in 2021
Figure 22. Gonadotropin-releasing Hormone Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Gonadotropin-releasing Hormone Antagonists Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Gonadotropin-releasing Hormone Antagonists Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2017-2028)
Figure 26. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2017-2028)
Figure 27. North America Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028) & (USD Million)
Figure 28. Europe Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028) & (USD Million)
Figure 30. South America Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue (2017-2028) & (USD Million)
Figure 32. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2028)
Figure 33. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Type (2017-2028)
Figure 34. Global Gonadotropin-releasing Hormone Antagonists Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2028)
Figure 36. Global Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Application (2017-2028)
Figure 37. Global Gonadotropin-releasing Hormone Antagonists Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2028)
Figure 39. North America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2028)
Figure 40. North America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2017-2028)
Figure 41. North America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2017-2028)
Figure 42. United States Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2028)
Figure 46. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2028)
Figure 47. Europe Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2017-2028)
Figure 48. Europe Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2017-2028)
Figure 49. Germany Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2017-2028)
Figure 58. China Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2028)
Figure 65. South America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2028)
Figure 66. South America Gonadotropin-releasing Hormone Antagonists Sales Market Share by Country (2017-2028)
Figure 67. South America Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Gonadotropin-releasing Hormone Antagonists Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Gonadotropin-releasing Hormone Antagonists Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Gonadotropin-releasing Hormone Antagonists in 2021
Figure 79. Manufacturing Process Analysis of Gonadotropin-releasing Hormone Antagonists
Figure 80. Gonadotropin-releasing Hormone Antagonists Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のホルモン放出IUD市場2022年：市場規模予測（～2028年）
  • 黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • 世界のプロゲストーゲン放出IUD市場2022年：市場規模予測（～2028年）
  • 世界のGnRH受容体拮抗薬市場2022年：市場規模予測（～2028年）
  • 世界の移植可能型ホルモンペレット市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19362 )"世界のゴナドトロピン放出ホルモン拮抗薬市場2022年：市場規模予測（～2028年）" (英文：Global Gonadotropin-releasing Hormone Antagonists Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。